We are live on ! Find out more
Renaissance Technologies

Renaissance Technologies Portfolio holdings

AUM $63.9B
1-Year Est. Return 45.56%
 

Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.

This Fund
S&P 500
This Quarter Est. Return
+6.64%
1 Year Est. Return
+45.56%
3 Year Est. Return
+129.95%
5 Year Est. Return
+153.6%
10 Year Est. Return
+738.07%
AUM
$56.6B
AUM Growth
+$4.03B
Cap. Flow
+$1.92B
Cap. Flow %
3.4%
Top 10 Hldgs %
7.89%
Holding
3,713
New
414
Increased
1,834
Reduced
1,026
Closed
416

Sector Composition

Rank Sector Weight
1 Technology 15.61%
2 Healthcare 12.42%
3 Financials 11.99%
4 Consumer Staples 9.6%
5 Industrials 9.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DCTH
3126
DELISTED
Delcath Systems Inc
DCTH
$148K ﹤0.01%
+59,914
New +$233K
PW
3127
Power REIT
PW
$3.23M
$147K ﹤0.01%
1,810
+290
+19% +$21.7K
ENLV icon
3128
Enlivex Ltd
ENLV
$37.7M
$146K ﹤0.01%
141
+101
+253% +$103K
AGRX
3129
DELISTED
Agile Therapeutics
AGRX
$144K ﹤0.01%
+10
New +$143K
NBSE
3130
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
$143K ﹤0.01%
127
+72
+131% +$77.7K
FPP
3131
DELISTED
FieldPoint Petroleum Corporation
FPP
$142K ﹤0.01%
244,400
+900
+0.4% +$627
SJT
3132
San Juan Basin Royalty Trust
SJT
$117M
$141K ﹤0.01%
23,825
+8,700
+58% +$54.6K
QUOT
3133
DELISTED
Quotient Technology Inc
QUOT
$141K ﹤0.01%
+10,600
New +$141K
RVP icon
3134
Retractable Technologies
RVP
$20.1M
$138K ﹤0.01%
54,100
+9,000
+20% +$22.8K
ABAC
3135
DELISTED
Renmin Tianli Group, Inc. Common Shares
ABAC
$138K ﹤0.01%
71,275
+8,675
+14% +$24.2K
VII
3136
DELISTED
Vicon Industries, Inc.
VII
$137K ﹤0.01%
193,300
+59,600
+45% +$45.1K
LSTA icon
3137
Lisata Therapeutics
LSTA
$10.6M
$135K ﹤0.01%
1,943
+1,861
+2,270% +$150K
NTIP icon
3138
Network-1 Technologies
NTIP
$37.3M
$135K ﹤0.01%
49,600
+39,484
+390% +$106K
CIA icon
3139
Citizens
CIA
$257M
$134K ﹤0.01%
14,300
-22,800
-61% -$212K
DXTR
3140
DELISTED
Dextera Surgical Inc.
DXTR
$133K ﹤0.01%
70,672
+5,500
+8% +$11.7K
ACUR
3141
DELISTED
Acura Pharmaceuticals
ACUR
$131K ﹤0.01%
81,920
+6,300
+8% +$11.2K
DAC icon
3142
Danaos Corp
DAC
$2.56B
$130K ﹤0.01%
+3,464
New +$175K
XPL icon
3143
Solitario Resources
XPL
$67.9M
$130K ﹤0.01%
196,575
+55,975
+40% +$42.9K
JMP
3144
DELISTED
JMP Group LLC
JMP
$129K ﹤0.01%
23,333
+4,270
+22% +$23.8K
AMPE
3145
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$128K ﹤0.01%
+579
New +$162K
PTN
3146
Palatin Technologies
PTN
$13.7M
$126K ﹤0.01%
160
-14
-8% -$9.83K
HSTO
3147
DELISTED
Histogen Inc. Common Stock
HSTO
$125K ﹤0.01%
+313
New +$128K
MTL.PR
3148
DELISTED
Mechel PAO American Depositary Shares (each representing one-half of a Preferred Share)
MTL.PR
$124K ﹤0.01%
222,800
+1,900
+0.9% +$718
RNVA
3149
DELISTED
Rennova Health, Inc.
RNVA
$123K ﹤0.01%
1,448
+1,394
+2,581% +$183K
JASN
3150
DELISTED
Jason Industries, Inc.
JASN
$122K ﹤0.01%
55,000
+24,400
+80% +$67.5K

Similar funds

Renaissance Technologies's Q3 2016 Portfolio in Review

As of Q3 2016, Renaissance Technologies held 3,713 positions worth $56.6B, up 7.7% from $52.5B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.

Renaissance Technologies deployed $1.92B of net new capital in Q3 2016, opening 414 new positions and adding to 1,834 existing holdings. Its largest new stake was FedEx: 811,400 shares worth $142M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was CVS Health, an estimated $274M trimmed.

  • Renaissance Technologies's largest Q3 2016 buy was FedEx: 811,400 shares worth $142M.
  • Renaissance Technologies added most to Alphabet (Google) Class A in Q3 2016, an estimated $373M increase.
  • Renaissance Technologies's biggest Q3 2016 reduction was CVS Health, cutting an estimated $274M.
  • Renaissance Technologies fully exited EMC CORPORATION in Q3 2016, selling an estimated $228M.
  • Renaissance Technologies's ten largest holdings make up 7.9% of its $56.6B portfolio in Q3 2016.
  • Renaissance Technologies opened 414 new positions and closed 416 in Q3 2016.
  • Renaissance Technologies's portfolio value rose 7.7% quarter-over-quarter to $56.6B.

Based on Renaissance Technologies's 13F filing for Q3 2016, filed 14 Nov 2016.